{"id":"https://openalex.org/W4309449754","doi":"https://doi.org/10.1101/2022.11.18.22282414","title":"Immunogenicity and safety of a 4 th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial","display_name":"Immunogenicity and safety of a 4 th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial","publication_year":2022,"publication_date":"2022-11-20","ids":{"openalex":"https://openalex.org/W4309449754","doi":"https://doi.org/10.1101/2022.11.18.22282414"},"language":"en","primary_location":{"id":"doi:10.1101/2022.11.18.22282414","doi":"https://doi.org/10.1101/2022.11.18.22282414","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2022.11.18.22282414","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2022/11/20/2022.11.18.22282414.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2022/11/20/2022.11.18.22282414.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002761122","display_name":"Katia Alves","orcid":"https://orcid.org/0000-0002-4181-2051","observed_orcids":["https://orcid.org/0000-0002-4181-2051"]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katia Alves","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017931794","display_name":"Joyce S. Plested","orcid":"https://orcid.org/0009-0007-0283-0779","observed_orcids":["https://orcid.org/0009-0007-0283-0779"]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joyce S Plested","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084622226","display_name":"Shirley Galbiati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shirley Galbiati","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112396854","display_name":"Gordon Chau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gordon Chau","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081746974","display_name":"Shane Cloney-Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shane Cloney-Clark","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102779480","display_name":"Mingzhu Zhu","orcid":"https://orcid.org/0009-0005-1628-7442","observed_orcids":["https://orcid.org/0009-0005-1628-7442"]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mingzhu Zhu","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034631208","display_name":"Raj Kalkeri","orcid":"https://orcid.org/0000-0002-1188-277X","observed_orcids":["https://orcid.org/0000-0002-1188-277X"]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raj Kalkeri","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103002412","display_name":"Nita Patel","orcid":"https://orcid.org/0000-0001-5635-0294","observed_orcids":["https://orcid.org/0000-0001-5635-0294","https://orcid.org/0000-0003-4976-061X"]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nita Patel","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109245886","display_name":"Kathy Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathy Smith","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080207020","display_name":"Alex Marcheschi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Marcheschi","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Susan Pfeiffer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Pfeiffer","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001644964","display_name":"Heather McFall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather McFall","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000458556","display_name":"Gale Smith","orcid":"https://orcid.org/0000-0002-6482-6026","observed_orcids":["https://orcid.org/0000-0002-6482-6026"]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gale Smith","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032295889","display_name":"Gregory M. Glenn","orcid":"https://orcid.org/0000-0002-2030-8665","observed_orcids":["https://orcid.org/0000-0002-2030-8665"]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory M. Glenn","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016041349","display_name":"Filip Dubovsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Filip Dubovsky","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023414888","display_name":"Raburn M. Mallory","orcid":"https://orcid.org/0000-0002-2563-9981","observed_orcids":["https://orcid.org/0000-0002-2563-9981"]},"institutions":[{"id":"https://openalex.org/I4210100774","display_name":"Novavax (United States)","ror":"https://ror.org/01bhs6g30","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100774"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Raburn M. Mallory","raw_affiliation_strings":["Novavax, Inc., Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novavax, Inc., Gaithersburg, MD","institution_ids":["https://openalex.org/I4210100774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023414888"],"corresponding_institution_ids":["https://openalex.org/I4210100774"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nvx-cov2373","display_name":"NVX-CoV2373","score":0.9470000267028809},{"id":"https://openalex.org/keywords/homologous-booster","display_name":"homologous booster","score":0.8420000076293945},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8349999785423279},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.7770000100135803},{"id":"https://openalex.org/keywords/reactogenicity","display_name":"reactogenicity","score":0.9580000042915344},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.796999990940094},{"id":"https://openalex.org/keywords/omicron-sublineages","display_name":"Omicron subvariants","score":0.8820000290870667},{"id":"https://openalex.org/keywords/sars-cov-2-variants-of-concern","display_name":"SARS-CoV-2 variants of concern","score":0.8949999809265137},{"id":"https://openalex.org/keywords/antigenic-cartography","display_name":"antigenic cartography","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cross-reactive-antibodies","display_name":"cross-reactive antibodies","score":0.7480000257492065},{"id":"https://openalex.org/keywords/matrix-m-adjuvant","display_name":"Matrix-M adjuvant","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C2777704310","wikidata":"https://www.wikidata.org/wiki/Q7300322","display_name":"Reactogenicity","level":4,"score":0.9854917526245117},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8466784954071045},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.662506103515625},{"id":"https://openalex.org/C12590561","wikidata":"https://www.wikidata.org/wiki/Q2920497","display_name":"Booster dose","level":4,"score":0.6161624789237976},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5338935256004333},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5214502215385437},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.5103113055229187},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4631236493587494},{"id":"https://openalex.org/C2777289321","wikidata":"https://www.wikidata.org/wiki/Q4007170","display_name":"Anthrax vaccines","level":5,"score":0.44980019330978394},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4441642463207245},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.4400786757469177},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4138838052749634},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3896288573741913},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.37164339423179626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29916277527809143},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.23831623792648315},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C167508917","wikidata":"https://www.wikidata.org/wiki/Q578537","display_name":"DNA vaccination","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1101/2022.11.18.22282414","doi":"https://doi.org/10.1101/2022.11.18.22282414","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2022.11.18.22282414","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2022/11/20/2022.11.18.22282414.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1101/2022.11.18.22282414","doi":"https://doi.org/10.1101/2022.11.18.22282414","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2022.11.18.22282414","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2022/11/20/2022.11.18.22282414.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320314772","display_name":"Novavax","ror":"https://ror.org/01bhs6g30"},{"id":"https://openalex.org/F4320316507","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4309449754.pdf","grobid_xml":"https://content.openalex.org/works/W4309449754.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1979158913","https://openalex.org/W2190981469","https://openalex.org/W2749306127","https://openalex.org/W2808629568","https://openalex.org/W3008187404","https://openalex.org/W3175514659","https://openalex.org/W3203630421","https://openalex.org/W4206611537","https://openalex.org/W4214657299","https://openalex.org/W4220734224","https://openalex.org/W4220928249","https://openalex.org/W4223451368","https://openalex.org/W4224984590","https://openalex.org/W4226023532","https://openalex.org/W4229458272","https://openalex.org/W4283817451","https://openalex.org/W4284886202","https://openalex.org/W4290987220"],"related_works":["https://openalex.org/W4379184414","https://openalex.org/W4290987220","https://openalex.org/W4411046868","https://openalex.org/W4386242851","https://openalex.org/W4360989516","https://openalex.org/W4388717514","https://openalex.org/W4389049137","https://openalex.org/W4313439133","https://openalex.org/W4311732172","https://openalex.org/W4382567783"],"abstract_inverted_index":{"Summary":[0],"Background":[1],"The":[2,151],"emergence":[3],"of":[4,12,19,33,38,50,56,76,136,149,153,163,177,209,216,237],"SARS-CoV-2":[5,22,107,204,231],"variants":[6,37,232],"has":[7],"significantly":[8],"reduced":[9],"the":[10,74,105,132,159,243],"efficacy":[11],"some":[13],"approved":[14],"vaccines.":[15],"A":[16,41,213],"fourth":[17,48,65,97,147,214,235],"dose":[18,49,98,148,169,180,215,236],"NVX-CoV2373":[20,51,210,217],"(5\u00b5g":[21],"rS":[23],"+":[24],"50\u00b5g":[25],"Matrix-M\u2122":[26],"adjuvant)":[27],"was":[28,72,90],"evaluated":[29],"to":[30,36,130,242],"determine":[31],"induction":[32],"cross-reactive":[34],"antibodies":[35],"concern.":[39],"Methods":[40],"phase":[42],"2":[43],"randomized":[44,129],"study":[45],"assessed":[46,73,114],"a":[47,140,146,226,234],"in":[52,175,197],"adults":[53],"18\u201384":[54],"years":[55],"age":[57],"(2-dose":[58],"primary":[59,134],"series":[60],"followed":[61],"by":[62],"third":[63,141],"and":[64,78,93,109,119,143,165,202],"doses":[66,162],"at":[67],"6-month":[68],"intervals).":[69],"Local/systemic":[70],"reactogenicity":[71,155],"day":[75],"vaccination":[77],"for":[79],"6":[80],"days":[81,95],"thereafter.":[82],"Unsolicited":[83,171],"adverse":[84],"events":[85,156],"(AEs)":[86],"were":[87,128,173],"reported.":[88],"Immunogenicity":[89],"measured":[91],"before,":[92],"14":[94],"after,":[96],"administration":[99],"using":[100],"anti-spike":[101],"neutralization":[102],"assays":[103],"against":[104,230],"ancestral":[106,118,201],"strain":[108],"Omicron":[110],"sublineages.":[111],"Antigenic":[112,193,223],"cartography":[113,194,224],"antigenic":[115,198],"distances":[116],"between":[117,200],"variant":[120,203],"strains.":[121],"Results":[122],"Among":[123],"1283":[124],"enrolled":[125],"participants,":[126],"258":[127],"receive":[131],"2-dose":[133],"series,":[135],"whom":[137],"104":[138],"received":[139,145],"dose,":[142],"45":[144],"NVX-CoV2373.":[150],"incidence":[152],"local/systemic":[154],"increased":[157,189,207],"after":[158,168,179,233],"first":[160],"three":[161],"NVX-CoV2373,":[164,238],"leveled":[166],"off":[167],"four.":[170],"AEs":[172],"reported":[174],"9%":[176],"participants":[178],"4":[181],"(none":[182],"severe":[183],"or":[184],"serious).":[185],"Neutralization":[186],"antibody":[187],"titers":[188],"following":[190],"booster":[191],"doses.":[192,211],"demonstrated":[195,225],"reductions":[196],"distance":[199],"strains":[205],"with":[206],"number":[208,252],"Conclusions":[212],"enhanced":[218],"immunogenicity":[219],"without":[220],"increasing":[221],"reactogenicity.":[222],"more":[227],"universal-like":[228],"response":[229],"indicating":[239],"that":[240],"updates":[241],"vaccine":[244],"composition":[245],"may":[246],"not":[247],"be":[248],"warranted.":[249],"Trial":[250],"registration":[251],"NCT04368988":[253]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-11-28T00:00:00"}